Signpath Pharma Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Exelixis.
Founding Date | Founding Date 2000 | Founding Date 1994 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Alameda, US HQ |
Employees | Employees 82517% decrease | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 8.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods $83.7m (FY, 2025) |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit $2.2b (FY, 2025) |
Net income | Net income €162.2m (FY, 2024) | Net income $782.6m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View company